On-Demand Webinar: Complex, 3D Screening for Cancer Immunotherapy

Screening for potential anti-cancer immunotherapies benefits from 3D platforms to detect complex, multi-cell and multi-step effects on the immune system. Watch this on-demand webinar to learn: Differences between 2D and 3D drug screening models How 3D cultures can mimic cancer cell-immune cell interactions How to maximize reproducibility in a 3D drug screening assay Who Should […]

Read More…

Humanized Antibodies: Key Technology for Effective Immunotherapies

immunotherapy

Harnessing the power of the immune system for therapeutic use in human disease is not a new idea, but recent advances in biotechnology have brought new precision to the way physicians and researchers approach therapy development.  Monoclonal antibodies (mAbs) have offered real progress toward fighting many autoimmune diseases and several forms of cancer, turning immunotherapy […]

Read More…

Mass Spec: Shedding Light on Cancer Biomarkers with Century-Old Technology

cancer

Imagine telling the inventor of the radio that the technology he discovered was now found in almost every kitchen in America, and that you used it to make your popcorn last night. He’d probably be surprised, and maybe you are, too.  Sound far-fetched? Many aspects of modern life rely on technology that was first identified […]

Read More…

Two Papers Published in the Online Journal PeerJ; First Step to Reproducing Critical Prostate Cancer Findings.

papers

Science Exchange published two papers in PeerJ, the online journal, that are being funded by the Prostate Cancer Foundation-Movember Foundation Reproducibility Initiative. This initiative seeks to address growing concerns about reproducibility in scientific research by conducting replications of recent papers in the field of prostate cancer.  It is a collaboration between the Prostate Cancer Foundation, […]

Read More…

The Reproducibility Project: Cancer Biology Moves Forward

reproducibility-2

“Reproducibility is actually the heart of science. The fact that not everything is reproducible is not a surprise.” – Eric Lander, head of the Broad Institute at MIT in a recent Washington Post article.  “We’re always in a gray area between perfect truth and complete falsehood,” The best researchers can do is edge closer to truth. […]

Read More…

First Registered Reports for the Reproducibility Project: Cancer Biology are published

cancer-biology

We’re excited to announce that our introductory article and the first three of our Registered Reports have been published by our partner eLife. In “An open investigation of the reproducibility of cancer biology research”, the Reproducibility Project: Cancer Biology core team details the impetus for and the specific goals of the project: “The resulting open […]

Read More…